231 related articles for article (PubMed ID: 7833922)
1. The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient.
Pritchard-Jones K; Renshaw J; King-Underwood L
Hum Mol Genet; 1994 Sep; 3(9):1633-7. PubMed ID: 7833922
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
[TBL] [Abstract][Full Text] [Related]
3. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.
Pelletier J; Bruening W; Li FP; Haber DA; Glaser T; Housman DE
Nature; 1991 Oct; 353(6343):431-4. PubMed ID: 1654525
[TBL] [Abstract][Full Text] [Related]
4. Homozygous inactivation of WT1 in a Wilms' tumor associated with the WAGR syndrome.
Gessler M; König A; Moore J; Qualman S; Arden K; Cavenee W; Bruns G
Genes Chromosomes Cancer; 1993 Jul; 7(3):131-6. PubMed ID: 7687865
[TBL] [Abstract][Full Text] [Related]
5. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
Park S; Tomlinson G; Nisen P; Haber DA
Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
[TBL] [Abstract][Full Text] [Related]
6. Wilms tumour: a developmental anomaly.
Hastie ND; Bickmore W; Pritchard-Jones K; Porteous DJ; van Heyningen V
Princess Takamatsu Symp; 1989; 20():145-50. PubMed ID: 2562179
[TBL] [Abstract][Full Text] [Related]
7. Population-based risk estimates of Wilms tumor in sporadic aniridia. A comprehensive mutation screening procedure of PAX6 identifies 80% of mutations in aniridia.
Grønskov K; Olsen JH; Sand A; Pedersen W; Carlsen N; Bak Jylling AM; Lyngbye T; Brøndum-Nielsen K; Rosenberg T
Hum Genet; 2001 Jul; 109(1):11-8. PubMed ID: 11479730
[TBL] [Abstract][Full Text] [Related]
8. Insertional inactivation of the WT1 gene in tumour cells from a patient with WAGR syndrome.
Santos A; Osorio-Almeida L; Baird PN; Silva JM; Boavida MG; Cowell J
Hum Genet; 1993 Aug; 92(1):83-6. PubMed ID: 8396067
[TBL] [Abstract][Full Text] [Related]
9. Raised risk of Wilms tumour in patients with aniridia and submicroscopic WT1 deletion.
van Heyningen V; Hoovers JM; de Kraker J; Crolla JA
J Med Genet; 2007 Dec; 44(12):787-90. PubMed ID: 17630404
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of aniridia patients for deletions involving the Wilms' tumor gene.
Drechsler M; Meijers-Heijboer EJ; Schneider S; Schurich B; Grond-Ginsbach C; Tariverdian G; Kantner G; Blankenagel A; Kaps D; Schroeder-Kurth T
Hum Genet; 1994 Oct; 94(4):331-8. PubMed ID: 7927324
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of chromosome 11p imbalances in aniridia and Wilms tumor patients.
Busch M; Leube B; Thiel A; Schanze I; Beier M; Royer-Pokora B
Am J Med Genet A; 2013 May; 161A(5):958-64. PubMed ID: 23494989
[TBL] [Abstract][Full Text] [Related]
12. Genotype/phenotype correlations in Wilms' tumor.
Huff V
Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
[TBL] [Abstract][Full Text] [Related]
13. Polymerase chain reaction-based risk assessment for Wilms tumor in sporadic aniridia.
Gupta SK; De Becker I; Guernsey DL; Neumann PE
Am J Ophthalmol; 1998 May; 125(5):687-92. PubMed ID: 9625553
[TBL] [Abstract][Full Text] [Related]
14. [Hereditary renal tumors: Wilms' tumor--congenital anomalies' syndrome].
Tsuchida Y; Yokomori K; Choi SH
Nihon Rinsho; 1995 Nov; 53(11):2742-8. PubMed ID: 8538037
[TBL] [Abstract][Full Text] [Related]
15. Bilateral Wilms tumor in a boy with severe hypospadias and cryptochidism due to a heterozygous mutation in the WT1 gene.
Köhler B; Schumacher V; Schulte-Overberg U; Biewald W; Lennert T; l'Allemand D; Royer-Pokora B; Grüters A
Pediatr Res; 1999 Feb; 45(2):187-90. PubMed ID: 10022588
[TBL] [Abstract][Full Text] [Related]
16. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.
Grubb GR; Yun K; Reeve AE; Eccles MR
Oncogene; 1995 Apr; 10(8):1677-81. PubMed ID: 7731725
[TBL] [Abstract][Full Text] [Related]
17. Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome.
Baird PN; Groves N; Haber DA; Housman DE; Cowell JK
Oncogene; 1992 Nov; 7(11):2141-9. PubMed ID: 1331933
[TBL] [Abstract][Full Text] [Related]
18. Submicroscopic deletions at the WAGR locus, revealed by nonradioactive in situ hybridization.
Fantes JA; Bickmore WA; Fletcher JM; Ballesta F; Hanson IM; van Heyningen V
Am J Hum Genet; 1992 Dec; 51(6):1286-94. PubMed ID: 1334370
[TBL] [Abstract][Full Text] [Related]
19. The role of Wilms' tumor genes.
Hirose M
J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
[TBL] [Abstract][Full Text] [Related]
20. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients.
Segers H; Kersseboom R; Alders M; Pieters R; Wagner A; van den Heuvel-Eibrink MM
Eur J Cancer; 2012 Nov; 48(17):3249-56. PubMed ID: 22796116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
